Neon Therapeutics, Inc. Debt to Equity Ratio 2018-2020 | NTGN
Current and historical debt to equity ratio values for Neon Therapeutics, Inc. (NTGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Neon Therapeutics, Inc. debt/equity for the three months ending March 31, 2020 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2020-03-31 | $0.02B | $0.01B | 1.18 |
| 2019-12-31 | $0.02B | $0.03B | 0.58 |
| 2019-09-30 | $0.02B | $0.05B | 0.38 |
| 2019-06-30 | $0.02B | $0.06B | 0.28 |
| 2019-03-31 | $0.02B | $0.08B | 0.23 |
| 2018-12-31 | $0.01B | $0.10B | 0.13 |
| 2018-09-30 | $0.01B | $0.12B | 0.08 |
| 2018-06-30 | $0.01B | $0.14B | 0.07 |
| 2018-03-31 | $0.19B | $-0.11B | -1.66 |
| 2017-12-31 | $0.18B | $-0.09B | -1.97 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
